Osteoarthritis Trial, Recruiting NCT07094100 Sponsor: The First Affiliated Hospital of Xinxiang Medical College Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07094100
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years old (any gender)
  • Bone growth is fully mature, as shown on imaging scans
  • There is damage or localised injury to the cartilage in a joint, caused by trauma or another reason
  • The injured area is on the lower weight-bearing surface of the femoral condyle (a part of the knee), with no more than 4 damaged spots, and the cruciate ligaments in the knee are not injured
  • The person is willing to sign a consent form and commit to a strict rehabilitation program after surgery

Who may not be able to join:

  • People with a Body Mass Index (BMI) greater than 35 (considered very overweight)
  • People whose leg alignment is significantly off — specifically, the knee angles outward by more than 10° or inward by more than 5°
  • People who have injuries to more than one ligament
  • People with habits such as heavy smoking, drug use, or excessive alcohol consumption
  • People who have had open knee surgery within the past six months
  • People who have severe joint stiffness or scarring (fibrosis) in the joint
  • People who have allergies to collagen, or who have a history of serious allergic reactions in general
  • People with mental health conditions that affect their ability to participate
  • People who are unable or unwilling to take part in rehabilitation training
  • People with serious existing health conditions affecting daily life, such as heart disease, lung disease, hormonal or metabolic disorders, cancer, or AIDS
  • People who are pregnant, breastfeeding, or planning to become pregnant during the trial
  • People with other acute or chronic conditions where the research team considers surgery to be unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8613937354075

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

KSS score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov